1h Free Analyst Time
The prosthetic heart valves market is forecasted to grow by USD 4.82 billion during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the prosthetic heart valves market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of heart-related disorders, rising demand for mi procedures, and higher adoption of prosthetic heart valves.
The prosthetic heart valves market is segmented as below:
By Product
- Transcatheter heart valves
- Tissue heart valves
- Mechanical heart valves
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the prosthetic heart valves market covers the following areas:
- Prosthetic heart valves market sizing
- Prosthetic heart valves market forecast
- Prosthetic heart valves market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global prosthetic heart valves market: Abbott Laboratories, Anteris Technologies Ltd., Artivion Inc., Boston Scientific Corp., Braile Biomedica, Colibri Heart Valve LLC, Cryolife Inc., Edwards Lifesciences Corp., Foldax, Inc., Jc Medical Inc., JenaValve Technology Inc., Labcor Laboratorios Ltda., Lepu Medical Technology Beijing Co. Ltd., LivaNova PLC, Medtronic PLC, Meril Life Sciences Pvt. Ltd., Micro Interventional Devices Inc., MicroPort Scientific Corp., and TTK Healthcare Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is emergence of MRI-conditional heart valves."
According to the report, one of the major drivers for this market is the growing prevalence of heart-related disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Anteris Technologies Ltd.
- Artivion Inc.
- Boston Scientific Corp.
- Braile Biomedica
- Colibri Heart Valve LLC
- Cryolife Inc.
- Edwards Lifesciences Corp.
- Foldax Inc.
- Jc Medical Inc.
- JenaValve Technology Inc.
- Labcor Laboratorios Ltda.
- Lepu Medical Technology Beijing Co. Ltd.
- LivaNova PLC
- Medtronic Plc
- Meril Life Sciences Pvt. Ltd.
- Micro Interventional Devices Inc.
- MicroPort Scientific Corp.
- TTK Healthcare Ltd.
